EPAX Approved by TGA

LYSAKER, NorwayEPAX AS announced after 18 months of working closely with its Australian distributor, Pathway International, the company was granted regulatory approval from Australias Therapeutic Goods Administration (TGA), allowing the sale of EPAXs range of omega-3 products in complementary products in that country. The demand for omega-3 fatty acids is continuing to grow on a global basis, said Bjorn Refsum, chief executive officer (CEO) of EPAX AS. We are pleased customers in Australia will now have access to products from EPAX, as the company is known as one of the worlds leading suppliers of omega-3 concentrates.

For more information, visit www.epax.com or Booth #7021-7023 at SupplySide West.